chemical:semaglutide
Semaglutide & Liraglutide continue to be effective
Semaglutide and Liraglutide continue to be researched and studied and produce positive results for weight loss and medical outcomes.
includes:trial
drug:am-133
Amgen's GLP1: MariTide (formerly AMG-133)
Amgen is working on a new GLP1, entering the race -- AM-133. We dig into the trials and research and see if it's got any promise.
company:eli-lilly
Eli Lilly's other new GLP1 - Orforglipron
Eli Lilly is developing new GLP1 drugs, and Orforglipron is one of them. It's not easy to pronounce, but it is easy to take, and easy to produce.
drug:danuglipron
Pfizer's GLP1: Danuglipron
Read more about Dangulipron, Pfizer's GLP1 receptor agonist. Will it be better than Ozempic, Wegovy, Mounjaro, Zepbound and others?
chemical:servodutide
Survodutide, a new GLP1 + GCGR agonist
As the GLP1 Receptor Agonist class of drugs make much progress and receive a lot of attention, pharma companies are lining up to produce more and better kinds of GLP1 drugs. 🍃Don't know what a GLP1 Receptor Agonist is, or how drugs like Ozempic, Mounjaro, Wegovy, or Zepbound
drug:rybelsus
A pill instead of injection - A 2020 study on Rybelsus
Rybelsus is a form of Semaglutide that you can take as a pill, rather than injection. If you're not familiar with Semaglutide, it's one of the GLP1 Receptor Agonist class of drugs that are taking the world by storm right now (Ozempic, Wegovy, and Rybelsus are